Page last updated: 2024-09-04

ezetimibe and adenosine monophosphate

ezetimibe has been researched along with adenosine monophosphate in 2 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (adenosine monophosphate)	Trials (adenosine monophosphate)	Recent Studies (post-2010) (adenosine monophosphate)
2,484	563	1,465	11,432	257	2,798

Protein Interaction Comparison

Protein	Taxonomy	adenosine monophosphate (IC50)
Fructose-1,6-bisphosphatase 1	Sus scrofa (pig)	1.3
Fructose-1,6-bisphosphatase 1	Homo sapiens (human)	2.6436
Cytochrome P450 2C9	Homo sapiens (human)	2.6
Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)	0.1
Amine oxidase [flavin-containing] B	Rattus norvegicus (Norway rat)	0.44
Histamine H3 receptor	Rattus norvegicus (Norway rat)	0.8

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Adamska, U; Adamski, P; Koziński, M; Kubica, J; Ostrowska, M	1
Bašić-Jukić, N; Sabljić, Z	1

Reviews

1 review(s) available for ezetimibe and adenosine monophosphate

Article	Year
New directions for pharmacotherapy in the treatment of acute coronary syndrome. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:17 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Antibodies, Monoclonal; Anticholesteremic Agents; Clinical Trials as Topic; Drug Discovery; Ezetimibe; Humans; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Treatment Outcome	2016

Article

Year

New directions for pharmacotherapy in the treatment of acute coronary syndrome.

Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:17

Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Antibodies, Monoclonal; Anticholesteremic Agents; Clinical Trials as Topic; Drug Discovery; Ezetimibe; Humans; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Treatment Outcome

2016

Other Studies

1 other study(ies) available for ezetimibe and adenosine monophosphate

Article	Year
Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS-CoV-2 induced pneumonia: A case report. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022, Volume: 26, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Atorvastatin; COVID-19 Drug Treatment; Ezetimibe; Humans; Kidney Transplantation; Liver; Myotoxicity; Pneumonia; SARS-CoV-2; Tacrolimus	2022

Article

Year

Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS-CoV-2 induced pneumonia: A case report.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022, Volume: 26, Issue:2

Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Atorvastatin; COVID-19 Drug Treatment; Ezetimibe; Humans; Kidney Transplantation; Liver; Myotoxicity; Pneumonia; SARS-CoV-2; Tacrolimus

2022